2025 Annual Shareholders Meeting & Director Nominations

MEETING
Mon, Apr 28 2025 08:38 am

Annual Shareholders’ Meeting
EROAD intends to hold its annual shareholders’ meeting (ASM) on Friday 27 June 2025 at 1:00pm at Eden Park, World Cup Lounge West, 42 Reimers Ave, Kingsland, Auckland 1024, Gate G.

Director Nominations
For the purposes of NZX Listing Rule 2.3.2, the closing date for director nominations is Monday 12 May 2025. All nominations must be received by 5.00pm on the closing date.

Nominations must be made by a shareholder entitled to attend and vote at the ASM.

Any nominations should be forwarded in writing to:

Ksenija Chobanovich
General Counsel and Company Secretary
PO Box 305 394
Triton Plaza, North Shore 0757
Auckland

For further information please contact: [email protected]
Authorised for release to the NZX and ASX by EROAD’s General Counsel & Company Secretary, Ksenija Chobanovich.


Ends


For Investor enquiries please contact:
Jason Kepecs
[email protected]
NZ contact: +64 21 990 474
AU contact: +61 47 7711 136

For Media enquiries please contact:
Richard Llewellyn
[email protected]
+64 27 523 2362


About EROAD
EROAD (NZX/ASX: ERD) is a hardware-enabled SaaS company delivering safety, compliance, sustainability and efficiency solutions for complex vehicles fleets.
Its connected platform is used by commercial and government operators across New Zealand, Australia and North America to manage vehicles, assets and drivers with greater visibility and control. EROAD supports demanding, highly regulated fleet operations, including those moving food, concrete and aggregates, enabling them to operate smarter, safer and more sustainably.
EROAD’s platform is built on a foundation of regulatory expertise, having delivered the world’s first GPS-based road user charging system in New Zealand, where it remains the market leader today.
www.eroad.co.nz


Announcement PDF


Markets News

Auckland Airport dominates volumes; NZX dips 0.61%
Markets Market Close

Auckland Airport dominates volumes; NZX dips 0.61%

The S&P/ASX 200 has recovered from the US's so-called "Liberation Day".

Markets

Pacific Edge upbeat about latest move for new test

The median price for Cxbladder Triage Plus is US$1,018.44.

Pacific Edge upbeat about latest move for new test